Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.26B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.12B |
| 3 |
Apple
AAPL
|
+$986M |
| 4 |
Amazon
AMZN
|
+$676M |
| 5 |
Kenvue
KVUE
|
+$501M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.26B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$638M |
| 3 |
Microsoft
MSFT
|
+$630M |
| 4 |
Meta Platforms (Facebook)
META
|
+$578M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$453M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.36% |
| 2 | Consumer Discretionary | 1.65% |
| 3 | Financials | 1.08% |
| 4 | Healthcare | 0.89% |
| 5 | Communication Services | 0.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AUMN
11501
DELISTED
Golden Minerals Company
AUMN
| $23.9K | ﹤0.01% |
+37,390
| New | +$38.7K |
|
11502
PUT
Atossa Therapeutics
ATOS
$26.7M
| $23.6K | ﹤0.01% |
+2,127
| New | +$30.9K |
|
|
CMCM
11503
CALL
Cheetah Mobile
CMCM
$94M
| $23.6K | ﹤0.01% |
11,900
+1,100
| +10% | +$2.48K |
|
|
AACG
11504
ATA Creativity
AACG
$41.5M
| $23.4K | ﹤0.01% |
19,986
-1,109
| -5% | -$1.41K |
|
|
INCR
11505
Intercure
INCR
$69.7M
| $23.2K | ﹤0.01% |
2,932
+387
| +15% | +$3.09K |
|
|
OMQS
11506
DELISTED
OMNIQ Corp. Common Stock
OMQS
| $23.1K | ﹤0.01% |
+14,374
| New | +$39.6K |
|
11507
BuzzFeed
BZFD
$92.5M
| $23K | ﹤0.01% |
15,018
+2,334
| +18% | +$4.56K |
|
|
FSP
11508
PUT
Franklin Street Properties
FSP
$45.5M
| $22.9K | ﹤0.01% |
+12,400
| New | +$22K |
|
11509
Integrated Media Technology
IMTE
$1.63M
| $22.9K | ﹤0.01% |
+11,776
| New | +$32.3K |
|
|
PHLT
11510
DELISTED
Performant Healthcare Inc
PHLT
| $22.8K | ﹤0.01% |
10,070
-22,731
| -69% | -$57.7K |
|
11511
PUT
Hydrofarm Holdings
HYFM
$4.53M
| $22.7K | ﹤0.01% |
1,860
-2,420
| -57% | -$27K |
|
11512
Neonode
NEON
$15.3M
| $22.6K | ﹤0.01% |
14,146
-43,354
| -75% | -$127K |
|
11513
CALL
IZEA Worldwide
IZEA
$53.3M
| $22.5K | ﹤0.01% |
+10,400
| New | +$23.9K |
|
11514
CALL
MediciNova
MNOV
$77.3M
| $22.4K | ﹤0.01% |
10,700
-4,600
| -30% | -$10.7K |
|
|
TRVN
11515
CALL
DELISTED
Trevena, Inc.
TRVN
| $22.3K | ﹤0.01% |
+1,488
| New | +$32.2K |
|
11516
PUT
The Honest Company
HNST
$590M
| $22.3K | ﹤0.01% |
17,700
+4,500
| +34% | +$6.59K |
|
11517
Traws Pharma
TRAW
$8.9M
| $22.2K | ﹤0.01% |
+1,229
| New | +$28K |
|
|
11518
CALL
The Honest Company
HNST
$590M
| $21.9K | ﹤0.01% |
+17,400
| New | +$25.5K |
|
|
11519
CALL
BuzzFeed
BZFD
$92.5M
| $21.9K | ﹤0.01% |
14,375
-825
| -5% | -$1.61K |
|
|
BFI
11520
DELISTED
BurgerFi International, Inc. Common Stock
BFI
| $21.7K | ﹤0.01% |
18,749
-29,266
| -61% | -$45.3K |
|
11521
CALL
X4 Pharmaceuticals
XFOR
$412M
| $21.6K | ﹤0.01% |
660
-2,110
| -76% | -$92K |
|
11522
PUT
Absci
ABSI
$1.65B
| $21.5K | ﹤0.01% |
16,300
-35,300
| -68% | -$61.8K |
|
|
CIFRW
11523
DELISTED
Cipher Mining Warrant
CIFRW
| $21.4K | ﹤0.01% |
50,000
| – | – |
|
|
PTN
11524
Palatin Technologies
PTN
$18.5M
| $21.4K | ﹤0.01% |
+283
| New | +$29.8K |
|
11525
Laird Superfood
LSF
$46M
| $21.3K | ﹤0.01% |
+20,683
| New | +$22.2K |
|
Similar funds
Jeff Yass's Q3 2023 Portfolio in Review
As of Q3 2023, Jeff Yass held 13,532 positions worth $481B, down 2.3% from $492B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Jeff Yass's Q3 2023 filing shows 1,585 new, 5,250 increased, 4,926 reduced and 1,614 closed positions. Its largest new stake was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M. The largest sale was NVIDIA, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 2.7% a quarter earlier, followed by Consumer Discretionary and Financials.
- Jeff Yass's largest Q3 2023 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 632,356 shares worth $52.2M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.26B increase.
- Jeff Yass's biggest Q3 2023 reduction was NVIDIA, cutting an estimated $1.26B.
- Jeff Yass fully exited Magellan Midstream Partners, L.P. in Q3 2023, selling an estimated $45.6M.
- Jeff Yass's ten largest holdings make up 28% of its $481B portfolio in Q3 2023.
- Jeff Yass opened 1,585 new positions and closed 1,614 in Q3 2023.
- Jeff Yass's portfolio value fell 2.3% quarter-over-quarter to $481B.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.